Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 31, 2017

View Archived Issues

Use of virus-specific T cells proves safe and effective for treating viral infections after HSCT

Use of 3D printing of aqueous droplets for low-cost tissue engineering

FDA approves Vabomere for complicated urinary tract infections

MilliporeSigma collaborates with Angiex to support development of ADC therapy for cancer

Yisheng reports promise of YS-ON-001 in multiple animal models of solid tumors

Treating angina with ivabradine/metoprolol FDC shows promise

FDA approves CAR-T cell therapy Kymriah for B-cell precursor ALL in children and young adults

FDA approval for Actemra to treat CAR T-cell-induced cytokine release syndrome

Merck & Co. glycoconjugate delivers insulin depending on glucose levels

AP-14145 shows selective SK channel targeting

CSL Behring to acquire Calimmune

Regenacy Pharmaceuticals discloses novel HDAC inhibitors

FDA accepts for review sNDA to add OS data to Kyprolis label

Kyowa Hakko Kirin presents antisense oligonucleotides as CFB supressors

Innovent Biologics divulges anti-PD-1 antibodies for treating cancer

FDA approves Austedo to treat tardive dyskinesia in adults

Institut National de la Recherche Agronomique discovers Enterococci to treat respiratory disorders

University of North Carolina at Chapel Hill discloses siRNAs targeting KRAS

Phase III trial of Otividex in Meniere's disease misses primary endpoint

University of California, Oakland divulges new vectors encoding LAMP-2 isoforms

Johns Hopkins University presents mutant GAPDH for treating liver cancer

Bioverativ studies BIVV-001 for severe hemophilia A in phase I/IIa trial

Phase II trial explores use of MBS-2320 in active rheumatoid arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...